Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $154.9500 (12.69%) ($154.9500 - $154.9500) on Wed. May. 2, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.22% (three month average) | RSI | 56 | Latest Price | $154.9500(12.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -3.61% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.61% (StdDev 7.22%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $145.48(6.51%) | 10 Day Moving Average | $143.53(7.96%) | 20 Day Moving Average | $148.69(4.21%) | To recent high | -46.6% | To recent low | 19.2% | Market Cap | $3.052b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |